HEMOLYTIC-UREMIC SYNDROME
Clinical trials for HEMOLYTIC-UREMIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HEMOLYTIC-UREMIC SYNDROME trials appear
Sign up with your email to follow new studies for HEMOLYTIC-UREMIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough treatment trial aims to save kids from deadly e. coli kidney damage
Disease control Recruiting nowThis study is testing whether adding a new antibody treatment called INM004 to standard care helps children recover faster from a serious kidney condition caused by E. coli infection. The trial involves 220 children aged 9 months to 18 years who have developed kidney damage after…
Matched conditions: HEMOLYTIC-UREMIC SYNDROME
Phase: PHASE3 • Sponsor: Inmunova S.A. • Aim: Disease control
Last updated Apr 02, 2026 04:12 UTC
-
New test could pinpoint cause of devastating blood clotting disease
Diagnosis Recruiting nowThis study is testing a new laboratory method called the 'HMEC test' to better diagnose the underlying cause of a rare and severe condition called thrombotic microangiopathy (TMA). TMA causes dangerous blood clots in small vessels, often damaging the kidneys and brain. Researcher…
Matched conditions: HEMOLYTIC-UREMIC SYNDROME
Sponsor: Maastricht University Medical Center • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC